I don't know if we are at the bottom(although I believe we are close if not there), but if Nick continues to deliver, the share price will rebound and move higher, as quickly as it went down. Currently we are caught up in the negative market sentiment, but this too will right itself.
Even though we are not a Biotech anymore, we have been trading much like other Biotechs in the NBI and largely following the index of late. As far as Ziebell and Hart go, with regards to selling their options, I totally believe this is a non event and we cannot read anything into this.
I also continue to believe that new highs are instore for us in 2022. We just may have to be patient in this current market environment.
Market Data 
Markets 
AI
